Mechanistic and outcomes studies are warranted to elucidate the lipid paradox and CVD risk in rheumatoid arthritis (RA).
Changes to restrictions for telemedicine may have important implications for the management of adult and pediatric diabetes during the COVID-19 pandemic.
Familial hypercholesterolemia is one of the most clinically relevant monogenic disorders contributing to the development of atherosclerotic cardiovascular disease.
The clinical approach to management of Cushing disease is often complex and education on a clear approach is paramount.
The benefits of treating overt hypothyroidism in women who are pregnant or planning pregnancy are clear, but there is less clarity regarding the maternofetal and neonatal effects of subclinical hypothyroidism.
Emerging evidence suggests that the extrapulmonary effects of pulmonary arterial hypertension may manifest in the form of vascular dysfunction in systemic circulation, metabolic/endocrine dysfunction, and skeletal and respiratory muscle dysfunction.
Evidence suggests that even after optimal treatment with surgical and pharmacologic interventions, health-related quality of life remains impaired in patients with pituitary disease.
Rates of marijuana use are especially high among men and women of reproductive age. How should physicians advise patients who are trying to conceive about marijuana?
Although high-density lipoprotein cholesterol has been deemed the “good cholesterol,” this label may be misleading and outdated given that there is little evidence to support a causal relationship with CVD risk reduction.